Hydrogen Sulfide and Inflammatory Joint Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|18|14|1641-1652

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.14, 2017-10, pp. : 1641-1652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydrogen Sulfide-Based Anti-Inflammatory and Chemopreventive Therapies: An Experimental Approach

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 3012-3022

Bentham Science Publishers

Access to resources Recommend Favorite

The Neurophysiology of Hydrogen Sulfide

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 2, 2011-04 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment

By MacFarlane Robert J   Graham Simon Matthew   Davies Peter SE   Korres Nectarios   Tsouchnica Helen   Heliotis Manolis   Mantalaris Athanasios   Tsiridis Eleftherios  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 243-254

Informa Healthcare

Access to resources Recommend Favorite

Intraarticular Application of Unsealed Beta-Emitting Radionuclides in the Treatment Course of Inflammatory Joint Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 1, 2002-04 ,pp. : 77-87

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 35, 2013-10 ,pp. : 6375-6381

Bentham Science Publishers

Access to resources Recommend Favorite